David D Dean

Title: David D Dean: Innovator in Calcium Binding Proteolipid Research

Introduction

David D Dean is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of biochemistry, particularly in the area of calcium binding proteolipids. With a total of 2 patents, his work has implications for various applications in medical and biological research.

Latest Patents

David D Dean's latest patents include innovative methods and compositions related to calcium binding proteolipids. The first patent focuses on the cloning and sequencing of DNA encoding a membrane-associated proteolipid capable of inducing in vitro calcium binding. This invention involves the extraction of a proteolipid from cultures, which is then separated into a lipid component and three apoproteins with molecular weights of approximately 5.0, 5.5, and 7.5 kDa, as determined by SDS-PAGE. Additionally, this patent includes the development of polyclonal and monoclonal antibodies directed against the membrane-associated proteolipid, along with immunological assays utilizing these antibodies. The second patent pertains to methods and compositions for encoding calcium binding proteolipids, specifically relating to the cloning and sequencing of DNA from C. matruchotii, which is then incorporated into vectors and host cells.

Career Highlights

David D Dean is affiliated with the University of Texas System, where he continues to advance his research in proteolipid technology. His work has garnered attention for its potential applications in various scientific fields.

Collaborations

David has collaborated with esteemed colleagues such as Barbara Dale Boyan and Simon Van Dijk, contributing to a rich environment of innovation and research.

Conclusion

David D Dean's contributions to the field of calcium binding proteolipids highlight his role as an influential inventor. His patents reflect a commitment to advancing scientific knowledge and technology.